Full Press Release Details
Zymeworks Appoints New Director.
ZYME
Zymeworks Appoints New Director
Key Takeaway: Zymeworks Appoints New Director
Price reaction · baseline $8.59 (2023-06-28 close) · hit after-hours · 1 other ZYME headline(s) in the window, move may be shared
day 0 close · peak
-0.6%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+23%
120-day peak, hindsight
Typical move
5.4%
average across 7 past catalysts
Cash runway
~35 mo
Minimal dilution risk
Lead asset
ZW49
Phase 1 · HER2-expressing Cancers